<DOC>
	<DOC>NCT00363753</DOC>
	<brief_summary>Pilot study of continuing aspirin versus switching to clopidogrel after stroke or transient ischemic attack.</brief_summary>
	<brief_title>Pilot Study of Continuing Aspirin Versus Switching to Clopidogrel After Stroke or Transient Ischemic Attack</brief_title>
	<detailed_description>Pilot study of continuing aspirin versus switching to clopidogrel after stroke or transient ischemic attack.</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Ischemic Attack, Transient</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<criteria>Age 18 and older. Stroke or transient ischemic attack (TIA) while taking aspirin within one week of consent. Women of childbearing potential will be included only if there is a negative pregnancy test and they agree to birth control during the treatment period. Any medical indication for a specific antiplatelet agent (aspirin, clopidogrel, ticlopidine, aggrenox), or an indication for a combination of antiplatelet agents. Any medical indication for anticoagulation, except subcutaneous heparin for deep vein thrombosis prophylaxis. Allergy to aspirin or clopidogrel.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2007</verification_date>
	<keyword>Transient ischemic attack</keyword>
	<keyword>Stroke</keyword>
	<keyword>Aspirin</keyword>
	<keyword>Clopidogrel</keyword>
</DOC>